BioSpecifics Technologies has raised an aggregate amount of $1.12 million through the sale of 50,000 unregistered shares of its common stock priced at $22.50 per share.
Subscribe to our email newsletter
The shares were purchased by certain private investors on August 19, 2008. The shares were sold in a company managed private investment in public equity transaction at a premium over the market price. BioSpecifics did not grant options nor pay any commissions for this transaction.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.